118 related articles for article (PubMed ID: 19154802)
1. Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses.
Ren W; Blasier R; Peng X; Shi T; Wooley PH; Markel D
Bone; 2009 Apr; 44(4):671-7. PubMed ID: 19154802
[TBL] [Abstract][Full Text] [Related]
2. Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model.
Ren W; Wu B; Peng X; Mayton L; Yu D; Ren J; Chen BD; Wooley PH
J Orthop Res; 2006 Feb; 24(2):280-90. PubMed ID: 16435361
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implants.
Tamaki Y; Takakubo Y; Goto K; Hirayama T; Sasaki K; Konttinen YT; Goodman SB; Takagi M
J Rheumatol; 2009 Mar; 36(3):598-608. PubMed ID: 19208601
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis.
Koulouvaris P; Ly K; Ivashkiv LB; Bostrom MP; Nestor BJ; Sculco TP; Purdue PE
J Orthop Res; 2008 Jan; 26(1):106-16. PubMed ID: 17729302
[TBL] [Abstract][Full Text] [Related]
5. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty.
Beraudi A; Stea S; Cremonini S; Visentin M; Toni A
Artif Organs; 2009 Jul; 33(7):538-43. PubMed ID: 19566730
[TBL] [Abstract][Full Text] [Related]
6. Emerging ideas: can erythromycin reduce the risk of aseptic loosening?
Ren W; Markel DC
Clin Orthop Relat Res; 2011 Aug; 469(8):2399-403. PubMed ID: 21584820
[TBL] [Abstract][Full Text] [Related]
7. Comparison of VEGF-producing cells in periprosthetic osteolysis.
Spanogle JP; Miyanishi K; Ma T; Epstein NJ; Smith RL; Goodman SB
Biomaterials; 2006 Jul; 27(21):3882-7. PubMed ID: 16540164
[TBL] [Abstract][Full Text] [Related]
8. [Involvement of immunogenetic factors in the development of periprosthetic osteolysis].
Gallo J; Mrázek F; Petrek M
Acta Chir Orthop Traumatol Cech; 2007 Aug; 74(4):247-52. PubMed ID: 17877940
[TBL] [Abstract][Full Text] [Related]
9. Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo.
Mao X; Pan X; Zhao S; Peng X; Cheng T; Zhang X
Inflammation; 2012 Aug; 35(4):1378-91. PubMed ID: 22391745
[TBL] [Abstract][Full Text] [Related]
10. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study.
Federico A; Tuccillo C; Grossi E; Abbiati R; Garbagna N; Romano M; Tiso A; Blanco Cdel V; Loguercio C
Eur Rev Med Pharmacol Sci; 2009; 13(4):285-93. PubMed ID: 19694343
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the RANKL/RANK/OPG System in Periprosthetic Osteolysis with Septic Loosening.
Wang L; Dai Z; Xie J; Liao H; Lv C; Hu Y
Inflammation; 2016 Feb; 39(1):218-227. PubMed ID: 26294373
[TBL] [Abstract][Full Text] [Related]
12. Cellular immune responses to orthopaedic implant materials following cemented total joint replacement.
Wooley PH; Petersen S; Song Z; Nasser S
J Orthop Res; 1997 Nov; 15(6):874-80. PubMed ID: 9497813
[TBL] [Abstract][Full Text] [Related]
13. Effect of alendronate on pseudomembrane cytokine expression in patients with aseptic osteolysis.
Holt G; Reilly J; Meek RM
J Arthroplasty; 2010 Sep; 25(6):958-63. PubMed ID: 19963333
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of periprosthetic erythromycin delivery for wear debris-induced inflammation and osteolysis.
Ren W; Zhang R; Hawkins M; Shi T; Markel DC
Inflamm Res; 2010 Dec; 59(12):1091-7. PubMed ID: 20607583
[TBL] [Abstract][Full Text] [Related]
15. Substance P stimulates production of interleukin 1beta and tumor necrosis factor alpha in fibroblasts from hip periprosthetic membrane.
Qian Y; Zeng BF; Zhang XL; Jiang Y
J Arthroplasty; 2008 Jun; 23(4):581-5. PubMed ID: 18514878
[TBL] [Abstract][Full Text] [Related]
16. [Experiment study of alendronate in the prevention and treatment of aseptic loosening of prosthesis].
Chen M; Zheng Q; Fang ZH; Kan WS
Zhongguo Gu Shang; 2008 May; 21(5):365-7. PubMed ID: 19108466
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils are active in total joint implant loosening.
Wozniak W; Markuszewski J; Wierusz-Kozlowska M; Wysocki H
Acta Orthop Scand; 2004 Oct; 75(5):549-53. PubMed ID: 15513485
[TBL] [Abstract][Full Text] [Related]
18. Potential use of erythromycin to prevent and treat prosthetic failure.
Zhang P; Qin L
J Clin Pharmacol; 2010 Aug; 50(8):858-60. PubMed ID: 20150525
[TBL] [Abstract][Full Text] [Related]
19. Periprosthetic tissue reactions observed at revision of total intervertebral disc arthroplasty.
Punt IM; Cleutjens JP; de Bruin T; Willems PC; Kurtz SM; van Rhijn LW; Schurink GW; van Ooij A
Biomaterials; 2009 Apr; 30(11):2079-84. PubMed ID: 19155064
[TBL] [Abstract][Full Text] [Related]
20. Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation.
Huss RS; Huddleston JI; Goodman SB; Butcher EC; Zabel BA
Arthritis Rheum; 2010 Dec; 62(12):3799-805. PubMed ID: 20848566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
